GA
Goldstein Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
9,833
-736
| -7% | -$17.8K | 0.03% | 163 |
|
|
2025
Q1 | $268K | Buy |
10,569
+132
| +1% | +$3.35K | 0.04% | 145 |
|
|
2024
Q4 | $277K | Sell |
10,437
-629
| -6% | -$16.7K | 0.04% | 144 |
|
|
2024
Q3 | $320K | Sell |
11,066
-104
| -0.9% | -$3.01K | 0.05% | 118 |
|
|
2024
Q2 | $313K | Sell |
11,170
-342
| -3% | -$9.57K | 0.05% | 109 |
|
|
2024
Q1 | $319K | Buy |
11,512
+78
| +0.7% | +$2.17K | 0.05% | 105 |
|
|
2023
Q4 | $329K | Sell |
11,434
-1,488
| -12% | -$42.8K | 0.06% | 133 |
|
|
2023
Q3 | $429K | Buy |
12,922
+1,046
| +9% | +$34.7K | 0.09% | 80 |
|
|
2023
Q2 | $436K | Buy |
11,876
+327
| +3% | +$12K | 0.09% | 80 |
|
|
2023
Q1 | $471K | Buy |
11,549
+1,052
| +10% | +$42.9K | 0.1% | 75 |
|
|
2022
Q4 | $538K | Buy |
+10,497
| New | +$538K | 0.13% | 71 |
|